Further studies that temporally separate the Dicer deletion and Kras activation events, as might be achieved using a tetracycline-regulated system [34], [35], are needed to further investigate time- and tumor stage-dependent influences of Dicer. The gene discussed is KRAS; the disease is neoplasm.